Pelengaris, Stella <br/><br/>
The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth.  [electronic resource] 

 -  Expert opinion on therapeutic targets  Oct 2003 
 - 623-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7631 
<br/><br/><label>Standard No.: </label>10.1517/14728222.7.5.623  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Basic Helix-Loop-Helix Leucine Zipper Transcription Factors--physiology<br/>Cell Cycle--drug effects<br/>Cell Differentiation--drug effects<br/>Cell Division--drug effects<br/>Coronary Restenosis--prevention & control<br/>Diabetes Mellitus--drug therapy<br/>Drug Design<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Genes, myc<br/>Genetic Therapy<br/>Glucose--metabolism<br/>Growth Substances--physiology<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>Insulin--metabolism<br/>Insulin Secretion<br/>Islets of Langerhans--metabolism<br/>Mice<br/>Mice, Transgenic<br/>Models, Biological<br/>Neoplasms--drug therapy<br/>Oligonucleotides, Antisense--therapeutic use<br/>Proto-Oncogene Mas<br/>Proto-Oncogene Proteins c-myc--antagonists & inhibitors<br/>RNA, Small Interfering--therapeutic use<br/>Repressor Proteins--physiology<br/>Transcription, Genetic<br/>Tumor Escape